Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current

Ravi Mangal Patel1, Patricia Wei Denning

  • 1Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Emory University School of Medicine, 2015 Uppergate Drive Northeast, 3rd Floor, Atlanta, GA 30322, USA.

Clinics in Perinatology
|February 19, 2013
PubMed

Insights

Preventive therapies for necrotizing enterocolitis (NEC) are crucial for preterm infants. Probiotics show promise in reducing NEC, but safety and dosing require further investigation for routine clinical use.

Area of Science:

  • Neonatal medicine
  • Gastroenterology
  • Microbiome research

Background:

  • Necrotizing enterocolitis (NEC) is a significant cause of illness and death in newborns.
  • Effective and safe preventive treatments for NEC are critically needed.
  • Probiotics are currently the most promising therapeutic approach for NEC in preterm infants.

Purpose of the Study:

  • To review current evidence on probiotics, prebiotics, and postbiotics for preterm infants.
  • To evaluate the therapeutic role of these agents in preventing NEC.
  • To address safety and dosing concerns regarding probiotic use.

Main Methods:

  • Systematic review of existing therapeutic trials and scientific literature.
  • Analysis of data on the efficacy and safety of probiotics, prebiotics, and postbiotics.
  • Evaluation of current clinical practice guidelines and research gaps.

Main Results:

  • Evidence suggests probiotics are effective in reducing NEC incidence in preterm infants.
  • Safety and optimal dosing of probiotics remain areas of concern for widespread adoption.
  • Prebiotics and postbiotics also present potential therapeutic benefits for NEC prevention.

Conclusions:

  • Probiotics represent a promising strategy for NEC prevention in preterm neonates.
  • Further research is needed to establish definitive safety protocols and optimal dosing regimens.
  • A comprehensive approach involving probiotics, prebiotics, and postbiotics may offer future solutions for NEC management.

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...